Mario Boccadoro

Mario Boccadoro

UNVERIFIED PROFILE

Are you Mario Boccadoro?   Register this Author

Register author
Mario Boccadoro

Mario Boccadoro

Publications by authors named "Mario Boccadoro"

Are you Mario Boccadoro?   Register this Author

100Publications

3357Reads

19Profile Views

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma.

Front Immunol 2018 27;9:2749. Epub 2018 Nov 27.

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.02749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277686PMC
September 2019

Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives.

Front Biosci (Landmark Ed) 2019 06 1;24:1284-1315. Epub 2019 Jun 1.

SSD Trapianto allogenico di cellule staminali, Department of Oncology, A.O.U. Citta della Salute e della Scienza di Torino, via Genova 3, 10126 Torino, Italy.

View Article

Download full-text PDF

Source
June 2019

FLAI induction regimen in elderly patients with acute myeloid leukemia.

Leuk Lymphoma 2019 Jun 4:1-2. Epub 2019 Jun 4.

a Department of Molecular Biotechnology and Health Sciences , University of Torino , Turin , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1620943DOI Listing
June 2019

A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma.

Br J Haematol 2018 12 19;183(5):828-831. Epub 2017 Dec 19.

Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15057DOI Listing
December 2018

CD38 as an immunotherapeutic target in multiple myeloma.

Expert Opin Biol Ther 2018 12 13;18(12):1209-1221. Epub 2018 Nov 13.

a Myeloma Unit, Division of Hematology , University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14712598.2018.1
Publisher Site
http://dx.doi.org/10.1080/14712598.2018.1544240DOI Listing
December 2018

Determining treatment intensity in elderly patients with multiple myeloma.

Expert Rev Anticancer Ther 2018 09 13;18(9):917-930. Epub 2018 Jul 13.

a Myeloma Unit, Division of Hematology , University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1496823DOI Listing
September 2018

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study.

Leukemia 2018 08 30;32(8):1803-1807. Epub 2018 Jan 30.

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0024-1DOI Listing
August 2018

A look at treatment strategies for relapsed multiple myeloma.

Expert Rev Anticancer Ther 2018 08 24;18(8):735-750. Epub 2018 May 24.

a Myeloma Unit, Division of Hematology , University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1477594DOI Listing
August 2018

Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients.

Br J Haematol 2018 07 6;182(2):165-167. Epub 2018 May 6.

Myeloma Unit, Division of Haematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15260DOI Listing
July 2018

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.

Curr Med Chem 2018 May 13. Epub 2018 May 13.

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino, Torino. Italy.

View Article

Download full-text PDF

Source
http://www.eurekaselect.com/162099/article
Publisher Site
http://dx.doi.org/10.2174/0929867325666180514114806DOI Listing
May 2018

Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.

Eur J Haematol 2018 Mar 15;100(3):304-307. Epub 2018 Jan 15.

Regional Center for Hemorrhagic and Thrombotic Diseases, Haematology Unit, City of Health and Science University Hospital of Molinette, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13014DOI Listing
March 2018

Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma.

Biol Blood Marrow Transplant 2018 01 4;24(1):189-193. Epub 2017 Oct 4.

Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy; Department of Oncology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791173075
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2017.09.017DOI Listing
January 2018

Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma.

Expert Opin Drug Metab Toxicol 2018 Jan 19;14(1):91-99. Epub 2017 Dec 19.

a Myeloma Unit, Division of Hematology , University of Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2018.1417388DOI Listing
January 2018

Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study.

Leuk Lymphoma 2017 11 12;58(11):2738-2740. Epub 2017 Apr 12.

a Hematology Service, Department of Cellular Biotechnology and Hematology , ' Sapienza' University , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1307360DOI Listing
November 2017

Systemic virotherapy for multiple myeloma.

Expert Opin Biol Ther 2017 11 10;17(11):1375-1387. Epub 2017 Aug 10.

a Myeloma Unit, Division of Hematology , University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2017.1364359DOI Listing
November 2017

Autologous transplant for myeloma: when the old meets the new.

Oncotarget 2017 Oct 8;8(53):90618-90619. Epub 2017 Oct 8.

Francesca Gay: Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21605DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710864PMC
October 2017

Updated analysis of CALGB (Alliance) 100104.

Authors:
Mario Boccadoro

Lancet Haematol 2017 09 17;4(9):e404-e405. Epub 2017 Aug 17.

Division of Haematology, University of Turin, Turin 10124, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026173014
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(17)30148-5DOI Listing
September 2017

Emerging drugs and combinations to treat multiple myeloma.

Oncotarget 2017 Sep 15;8(36):60656-60672. Epub 2017 Jul 15.

Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601169PMC
September 2017

Melphalan hydrochloride for the treatment of multiple myeloma.

Expert Opin Pharmacother 2017 Aug 10;18(11):1127-1136. Epub 2017 Jul 10.

a Myeloma Unit, Division of Hematology , Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1349102DOI Listing
August 2017

Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors.

Clin Lymphoma Myeloma Leuk 2017 08 17;17(8):471-478. Epub 2017 Jun 17.

Department of Molecular Biotechnology and Health Sciences, University of Turin, Struttura Semplice Dipartimentale Allogeneic Stem Cell Transplant, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.06.014DOI Listing
August 2017

Novel Immunotherapies for Multiple Myeloma.

Curr Hematol Malig Rep 2017 08;12(4):344-357

Myeloma Service, Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0397-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693669PMC
August 2017

How is patient care for multiple myeloma advancing?

Expert Rev Hematol 2017 06 19;10(6):551-561. Epub 2017 May 19.

b Myeloma Unit, Division of Hematology , University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1326814DOI Listing
June 2017

Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma.

Eur J Haematol 2017 Mar 5;98(3):289-295. Epub 2017 Jan 5.

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12834DOI Listing
March 2017

Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2017 Mar 27;23(3):388-397. Epub 2016 Dec 27.

Department of Oncology, AOU Città della Salute e della Scienza di Torino, Presidio Molinette, Torino, Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.12.632DOI Listing
March 2017

Magic pills: new oral drugs to treat chronic lymphocytic leukemia.

Expert Opin Pharmacother 2017 Mar 22;18(4):411-425. Epub 2017 Feb 22.

a Division of Hematology , University of Torino, AOU Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1293655DOI Listing
March 2017

How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience.

Br J Haematol 2017 02 23;176(4):669-671. Epub 2016 Feb 23.

Haematology Division, Università degli Studi di Torino, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13983DOI Listing
February 2017

Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma.

Expert Rev Anticancer Ther 2017 Jan 9;17(1):75-87. Epub 2016 Dec 9.

a Myeloma Unit, Division of Hematology , University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2017.1266264DOI Listing
January 2017

Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm.

Am J Hematol 2016 Sep 20;91(9):E353. Epub 2016 Jun 20.

Hematology Division, Università Degli Studi Di Torino, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24422DOI Listing
September 2016

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report.

J Hematol Oncol 2016 08 8;9(1):67. Epub 2016 Aug 8.

Department of Oncology, SSCVD Trapianto di Cellule Staminali, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0298-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977623PMC
August 2016

Anemia in the Elderly: not Always what it Seems.

Mediterr J Hematol Infect Dis 2016 25;8(1):e2016017. Epub 2016 Feb 25.

Hematology Division, Università degli Studi di Torino, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2016.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771143PMC
March 2016

Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.

Cytometry B Clin Cytom 2016 Jan 23;90(1):81-90. Epub 2015 Sep 23.

Divisione Universitaria Di Ematologia, AOU Città Della Salute E Della Scienza Di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21279DOI Listing
January 2016

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.

J Mol Diagn 2015 Nov 28;17(6):652-60. Epub 2015 Aug 28.

Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy; Hematology Division, A.O.S. Antonio, Biagio and Cesare Arrigo, Alessandria, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2015.05.007DOI Listing
November 2015

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.

Oncoimmunology 2015 Nov 26;4(11):e1047580. Epub 2015 May 26.

Laboratorio di Ematologia Oncologica; Centro di Ricerca in Medicina Sperimentale (CeRMS); Torino, Italy ; Dipartimento di Biotecnologie Molecolari e Scienze per la Salute; Università degli Studi di Torino ; Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1047580DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589055PMC
November 2015

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.

J Clin Oncol 2015 Oct 17;33(30):3459-66. Epub 2015 Aug 17.

Antonio Palumbo, Francesca Gay, Federica Cavallo, Alessandra Larocca, Francesca Donato, Chiara Cerrato, Luana Boccadifuoco, and Mario Boccadoro, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino; Giulia Benevolo, S.C. Ematologia A.O. Città della Salute e della Scienza di Torino; Tommasina Guglielmelli, University of Turin and San Luigi Hospital; Giovannino Ciccone, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino and CPO Piemonte, Torino; Francesco Di Raimondo, Ospedale Ferrarotto, Azienda Policlinico-OVE, University of Catania, Catania; Maria T. Petrucci, Sapienza University of Rome; Tommaso Caravita, Ematologia Ospedale S. Eugenio, Rome; Sara Pezzatti, Azienda Ospedaliera San Gerardo, Monza; Francesca Patriarca, DISM, University Hospital, Udine; Chiara Nozzoli, AOU Careggi, Florence; Donatella Vincelli, A.O "Bianchi-Melacrino-Morelli," Reggio Calabria; Pellegrino Musto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Referral Cancer Center of Basilicata, Rionero in Vulture; Paolo Corradini, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano; Michele Cavo, Institute of Hematology and Medical Oncology "Seràgnoli," Bologna University School of Medicine S. Orsola's University Hospital, Bologna, Italy; Izhar Hardan, Meir Medical Center, Kfar-Saba; Arnon Nagler, Tel Aviv University, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Roman Hajek, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic; Michel Delforge, University Hospital Leuven, Leuven, Belgium; Zhinuan Yu and Christian Jacques, Celgene, Summit, NJ; and Meletios A. Dimopoulos, National and Kapodistrian University of Athens, School of Medicine, Alexandra Hospital, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.2466DOI Listing
October 2015

Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs.

Expert Opin Biol Ther 2015 Jun 12;15(6):857-72. Epub 2015 Apr 12.

University of Torino, Presidio Molinette, and Department of Molecular Biotechnology and Health Sciences, Division of Hematology, A.O.U. Citta' della salute e della scienza di Torino, Presidio Molinette , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2015.1036735DOI Listing
June 2015

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.

Haematologica 2014 Oct 27;99(10):1605-10. Epub 2014 Jun 27.

Divisione di Ematologia dell'Università di Torino, Dipartimento di Biotecnologie Molecolari e Scienze della Salute, Italy Laboratorio di Ematologia Oncologica, Centro di Ricerca in Medicina Sperimentale (CeRMS), Italy Azienda Ospedaliera-Universitaria Città della Salute e della Scienza di Torino, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.105866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181257PMC
October 2014

Autologous transplantation and maintenance therapy in multiple myeloma.

N Engl J Med 2014 Sep;371(10):895-905

From the Myeloma Unit, Division of Hematology, University of Turin (A.P., F.C., F.G., C. Cerrato, M.G., P.O., M.B.), and Unit of Clinical Epidemiology and Centro di Referimento per l'Epidemiologia-Piemonte, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino (A.E., G.C.), Turin, Division of Hematology, Ospedale Ferrarotto, Azienda Policlinico-Ospedale Vittorio Emanuele, University of Catania, Catania (F.D.R.), Hematology, Sapienza University of Rome (M.T.P.), and Cattedra di Ematologia, Ospedale S. Eugenio-University Tor Vergata (T.C.), Rome, Divisione di Ematologia, Ospedale S. Gerardo, Monza (S.P.), La Struttura Complessa di Ematologia, Dipartimento di Ematologia ed Oncologia, Azienda Ospedaliera Niguarda Ca' Granda (A.C.), Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute (M.M.), and Division of Hematology and Bone Marrow Transplantation, IRCCS Istituto Nazionale dei Tumori-University of Milan (P.C.), Milan, Ematologia, Policlinico Federico II, Naples (L.C.), Clinica di Ematologia, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona (M.O.), Unità Operativa Complessa Ematologia 1, IRCCS Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genoa (A.M.C.), Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna (E.Z., M.C.), Clinica Ematologia, Dipartimento di Scienze Mediche Sperimentali e Cliniche, Azienda Ospedaliera-Universitaria di Udine, Udine (F.P.), Scientific Direction, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (P.M.), and Struttura Complessa Ematologia e Dipartimento Oncologia Medica, Spedali Civili di Brescia, Brescia (C. Crippa) - all in Italy; and the Hematology Division, Hadassah University Hospital, Jerusalem (D.B.Y.), and the Hematology Institute, Chaim Sheba Medical Center, Tel Hashomer (E.R., A.N.) - both in Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1402888DOI Listing
September 2014

Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.

Ann Hematol 2014 Aug 6;93(8):1391-400. Epub 2014 Apr 6.

Section of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Turin, via Genova, 3, 10126, Turin, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2047-7DOI Listing
August 2014

European perspective on multiple myeloma treatment strategies in 2014.

Oncologist 2014 Aug 25;19(8):829-44. Epub 2014 Jul 25.

Department of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria; Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands; Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom; Department of Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, Barcelona, Spain; Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Ospedale Molinette, Turin, Italy; Institute of Hematology and Medical Oncology, Seragnoli, Bologna, Italy; Haemato-Oncology Unit, Royal Marsden Hospital, Surrey, United Kingdom; Hematology Service, University Hospital La Fe, Valencia, Spain; Department of Hematology, University Hospital, Leuven, Belgium; Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece; Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany; Service d'Hématologie, Centre Hospitalier Universitaire, Lille, France; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; University Hospital, Nantes, France; Karolinska Institute, Stockholm, Sweden; Department of Hematology, Center Lillebaelt, University of Southern Denmark, Odense, Denmark; Clinica Universidad de Navarra, Centro Investigaciones Medicas Aplicada, Pamplona, Spain; Department of Hemato-oncology, University of Ostrava, Ostrava, Czech Republic; University of Giessen, Giessen, Germany.

View Article

Download full-text PDF

Source
http://szpiczak.org/lang/aktualnosci/publikacje/rok_2014/The
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2014-0042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122482PMC
August 2014

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.

J Clin Oncol 2014 Mar 21;32(7):634-40. Epub 2014 Jan 21.

Antonio Palumbo, Sara Bringhen, Alessandra Larocca, Valeria Magarotto, Paola Omedé, Roberto Mina, Mario Boccadoro, and Giulia Benevolo, Azienda Ospedaliera (A.O.) Città della Salute e della Scienza di Torino; Daniela Gottardi, A.O. Ordine Mauriziano; Roberto Passera, San Giovanni Battista Hospital, University of Torino, Torino; Davide Rossi and Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara; Francesco Di Raimondo, Ferrarotto Hospital, University of Catania, Catania; Francesca Patriarca, A.O. Universitaria, Udine; Anna Levi and Maria Teresa Petrucci, Sapienza University of Rome; Luca Franceschini, Tor Vergata University Hospital, Rome; Iolanda Donatella Vincelli, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria; Mariella Grasso, S. Croce e Carle Hospital, Cuneo; Renato Zambello, Università degli Studi di Padova, Padova; Vittorio Montefusco, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori Milano, University of Milano, Milan; Antonietta Pia Falcone, IRCCS Casa Sollievo della Sofferenza and Unità di Ematologia, San Giovanni Rotondo; Roberto Marasca, University of Modena, Modena; Fortunato Morabito, A.O. di Cosenza, Cosenza; Tommasina Guglielmelli, "S. Luigi Gonzaga" Hospital, Orbassano; Chiara Nozzoli, A.O. Universitaria Careggi, Firenze; Massimo Offidani, Ospedali Riuniti, Ancona; Roberto Ria, University of Bari "Aldo Moro" Medical School, Bari; Pellegrino Musto, IRCCS-Centro Regionale Oncologico Basilicata, Rionero in Vulture; and Michele Cavo, Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.0023DOI Listing
March 2014

The impact of response on bone-directed therapy in patients with multiple myeloma.

Blood 2013 Oct 23;122(17):2974-7. Epub 2013 Aug 23.

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-04-498139DOI Listing
October 2013

Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma.

Ther Adv Hematol 2013 Jun;4(3):189-98

Hematology Division I, Azienda ospedaliera San Giovanni Battista, Città della Salute e della Scienza, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620713480522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666448PMC
June 2013